Literature DB >> 9879670

Enzymatic properties of overexpressed human hexokinase fragments.

M Bianchi1, G Serafini, E Bartolucci, C Giammarini, M Magnani.   

Abstract

Full-length hexokinase (HK; ATP: D-hexose 6-phosphotransferase, EC 2.7.1.1), a truncate form of the enzyme lacking the first 11 amino acids (HK-11aa) and the 50 kDa C-terminal half ('mini'-HK) containing the catalytic domain, were overexpressed and purified to homogeneity to investigate the influence of the N-terminal region of human hexokinase type I (HK) on its regulatory properties. All forms of the enzyme are catalytically active with the HK-11aa being the most active. All the forms of HK showed the same affinity for glucose and MgATP and were also inhibited by glucose 6-phosphate (Glc 6-P) competitively vs. MgATP with similar Kis (28.5-37 microM). Glucose 1,6-bisphosphate (Glc 1,6-P2) was also a strong inhibitor of all HKs without significant differences among the different truncate forms of the enzyme (Kis 49.5-59 microM). At low concentrations (0-3 mM), Pi was able to reverse the sugar phosphate inhibition of the full-length HK and HK-11aa but not of the 'mini'-HK. In contrast, at high concentrations Pi was an inhibitor of all the hexokinases investigated. These findings confirm that Pi has a low affinity binding site on the C-terminal of HK while counteracts glucose 6-phosphate inhibition by binding to or requiring the N-terminal half of the enzyme. The first 11 N-terminal amino acids influence the specific activity of HK but are unable to affect the kinetic properties investigated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879670     DOI: 10.1023/a:1006962217495

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Residues putatively involved in binding of ATP and glucose 6-phosphate to a mammalian hexokinase: site-directed mutation at analogous positions in the N- and C-terminal halves of the type I isozyme.

Authors:  M Baijal; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

2.  PH dependence of the alpha-glucose 1,6-diphosphate inhibition of hexokinase II.

Authors:  I A Rose; J V Warms
Journal:  Arch Biochem Biophys       Date:  1975-12       Impact factor: 4.013

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Intracellular distribution of hexokinase in rabbit brain.

Authors:  M Magnani; G Serafini; R Crinelli; A Antonelli; M Malatesta; G Gazzanelli
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

5.  Solubilization, purification, and properties of rabbit brain hexokinase.

Authors:  M Magnani; G Serafini; V Stocchi; M Bossù; M Dachà
Journal:  Arch Biochem Biophys       Date:  1982-07       Impact factor: 4.013

6.  Studies on the mechanism of orthophosphate regulation of bovine brain hexokinase.

Authors:  W R Ellison; J D Lueck; H J Fromm
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

7.  Functional consequences of mutation of highly conserved serine residues, found at equivalent positions in the N- and C-terminal domains of mammalian hexokinases.

Authors:  M Baijal; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1992-10       Impact factor: 4.013

8.  Effect of inorganic phosphate on the reverse reaction of bovine brain hexokinase.

Authors:  L P Solheim; H J Fromm
Journal:  Biochemistry       Date:  1983-04-26       Impact factor: 3.162

9.  Rat brain hexokinase: the hydrophobic N-terminus of the mitochondrially bound enzyme is inserted in the lipid bilayer.

Authors:  G C Xie; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1988-12       Impact factor: 4.013

10.  Active site residues of human brain hexokinase as studied by site-specific mutagenesis.

Authors:  C Zeng; H J Fromm
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

View more
  2 in total

1.  Bovine hexokinase type I: full-length cDNA sequence and characterisation of the recombinant enzyme.

Authors:  Francesca Andreoni; Giordano Serafini; Maria Elena Laguardia; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Dehydroascorbic acid irreversibly inhibits hexokinase activity.

Authors:  M Fiorani; R De Sanctis; F Scarlatti; L Vallorani; R De Bellis; G Serafini; M Bianchi; V Stocchi
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.